Donaldson (DCI) is positioned for a demand recovery across its legacy filtration markets in manufacturing and transportation, Oppenheimer said Thursday in a note.
"We view execution and strategy as solid overall' following a fiscal Q4 earnings beat on Wednesday, Oppenheimer said.
The company expects fiscal 2026 earnings of $3.92 to $4.08 a share. Analysts polled by FactSet expect $3.89.
The profit trajectory of the life sciences segment, particularly bioprocessing, remains "levered swing factor" behind its medium-term return prospects, the note said.
Oppenheimer maintained its perform rating on Donaldson stock.
Price: 80.92, Change: -1.22, Percent Change: -1.49